IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0342083.html

Development and validation of the Tobacco Use Individual-level Simulation and Tracking (TwIST) Model

Author

Listed:
  • Sarah D Mills
  • Nicholas Tapp Hughes
  • Yu Zhang
  • Kurt M Ribisl
  • Christopher A Wiesen
  • Jiaqian Fan
  • Kristen Hassmiller Lich

Abstract

Simulation models of tobacco use behavior are useful analytic tools for projecting rates of tobacco use over time and identifying priority areas for intervention. This paper presents the Tobacco Use Individual-level Simulation and Tracking (TwIST) Model, an individual-based simulation model of tobacco use in the adult US population. We describe the model structure, data sources and parameters, and, in addition to future projections, compare modeled estimates of smoking prevalence to those from established surveys. The simulated population and model parameter estimates are informed by the Population Assessment of Tobacco and Health Study and other nationally representative datasets. To simulate tobacco use over time, we estimated 2nd order Markov models using multinomial logistic regression. To validate the model, we compared model estimates of tobacco use to data from three national surveys. The model estimates adult cigarette smoking rates will decline from a prevalence of 12.4% (95% uncertainty interval (95% UI): 12.2–12.8%) in 2020 to 9.6% (95% UI: 9.3–9.9%), 9.1% (95% UI: 8.9–9.4%), and 8.7% (95% UI: 8.5–9.0%) in 2030, 2040, and 2050, respectively. From 2020 through 2050, adults living in poverty are estimated to have a cigarette smoking rate 2.1–2.3 times higher than individuals living above the poverty line. The prevalence of menthol cigarette use will decline at a slower rate than the prevalence of non-menthol cigarette use (21% vs. 38% decline). Model projections of cigarette smoking prevalence typically fall within the 95% confidence intervals of prevalence estimates across three national surveys. Overall, the TwIST Model projects cigarette smoking prevalence rates that are similar to real-world estimates. If tobacco use continues based on current patterns, income-based disparities in smoking will persist and a growing proportion of individuals who smoke will use menthol cigarettes, which are known to be harder to quit.

Suggested Citation

  • Sarah D Mills & Nicholas Tapp Hughes & Yu Zhang & Kurt M Ribisl & Christopher A Wiesen & Jiaqian Fan & Kristen Hassmiller Lich, 2026. "Development and validation of the Tobacco Use Individual-level Simulation and Tracking (TwIST) Model," PLOS ONE, Public Library of Science, vol. 21(2), pages 1-17, February.
    • Handle: RePEc:plo:pone00:0342083
    DOI: 10.1371/journal.pone.0342083
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0342083
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0342083&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0342083?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Eline M. Krijkamp & Fernando Alarid-Escudero & Eva A. Enns & Hawre J. Jalal & M. G. Myriam Hunink & Petros Pechlivanoglou, 2018. "Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial," Medical Decision Making, , vol. 38(3), pages 400-422, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fernando Alarid-Escudero & Eline Krijkamp & Eva A. Enns & Alan Yang & M. G. Myriam Hunink & Petros Pechlivanoglou & Hawre Jalal, 2023. "A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example," Medical Decision Making, , vol. 43(1), pages 21-41, January.
    2. Isaac Corro Ramos & Talitha Feenstra & Salah Ghabri & Maiwenn Al, 2024. "Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling," PharmacoEconomics, Springer, vol. 42(7), pages 715-719, July.
    3. Koen Degeling & Jonathan Karnon & Michiel Ven & Alan Brennan & Hendrik Koffijberg, 2025. "Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer," Applied Health Economics and Health Policy, Springer, vol. 23(6), pages 961-975, November.
    4. Huang-Tz Ou & Jui-Hung Tsai & Yi-Lin Chen & Tzu-I. Wu & Li-Jun Chen & Szu-Chun Yang, 2025. "Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma," PharmacoEconomics, Springer, vol. 43(4), pages 429-440, April.
    5. Harry Hill & James Fotheringham & Jessica Potts & Ivonne Solis-Trapala & Mark Lambie & Sarah Damery & Kerry Allen & Allan Wailoo & Iestyn Williams & Simon Davies, 2025. "The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis," Applied Health Economics and Health Policy, Springer, vol. 23(5), pages 919-929, September.
    6. Paolo Candio & Koen B. Pouwels & David Meads & Andrew J. Hill & Laura Bojke & Claire Williams, 2022. "Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(7), pages 1151-1157, September.
    7. Mei-Chin Su & Yi-Jen Wang & Tzeng-Ji Chen & Shiao-Hui Chiu & Hsiao-Ting Chang & Mei-Shu Huang & Li-Hui Hu & Chu-Chuan Li & Su-Ju Yang & Jau-Ching Wu & Yu-Chun Chen, 2020. "Assess the Performance and Cost-Effectiveness of LACE and HOSPITAL Re-Admission Prediction Models as a Risk Management Tool for Home Care Patients: An Evaluation Study of a Medical Center Affiliated Home Care Unit in Taiwan," IJERPH, MDPI, vol. 17(3), pages 1-17, February.
    8. Anna Heath & Petros Pechlivanoglou, 2022. "Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity," Medical Decision Making, , vol. 42(5), pages 649-660, July.
    9. Yi-Shu Lin & James F O’Mahony & Joost Rosmalen, 2023. "A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R," PharmacoEconomics - Open, Springer, vol. 7(4), pages 507-523, July.
    10. Peter Shewmaker & Stavroula A. Chrysanthopoulou & Rowan Iskandar & Derek Lake & Earic Jutkowitz, 2022. "Microsimulation Model Calibration with Approximate Bayesian Computation in R: A Tutorial," Medical Decision Making, , vol. 42(5), pages 557-570, July.
    11. Stavroula A. Chrysanthopoulou & Carolyn M. Rutter & Constantine A. Gatsonis, 2021. "Bayesian versus Empirical Calibration of Microsimulation Models: A Comparative Analysis," Medical Decision Making, , vol. 41(6), pages 714-726, August.
    12. Yingying Zhang & Noemi Kreif & Vijay S. GC & Andrea Manca, 2024. "Machine Learning Methods to Estimate Individualized Treatment Effects for Use in Health Technology Assessment," Medical Decision Making, , vol. 44(7), pages 756-769, October.
    13. William, Jananie & Loong, Bronwyn & Hanna, Dana & Parkinson, Bonny & Loxton, Deborah, 2022. "Lifetime health costs of intimate partner violence: A prospective longitudinal cohort study with linked data for out-of-hospital and pharmaceutical costs," Economic Modelling, Elsevier, vol. 116(C).
    14. Elizabeth A. Handorf & J. Robert Beck & Andres Correa & Chethan Ramamurthy & Daniel M. Geynisman, 2023. "Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer," Medical Decision Making, , vol. 43(7-8), pages 949-960, October.
    15. Fernando Alarid-Escudero & Eline Krijkamp & Eva A. Enns & Alan Yang & M. G. Myriam Hunink & Petros Pechlivanoglou & Hawre Jalal, 2023. "An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example," Medical Decision Making, , vol. 43(1), pages 3-20, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0342083. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.